Trial in progress: Phase 1 study of the selective protein degrader ASP4396 in patients with locally advanced or metastatic solid tumors with

Authors: Shiraj Sen, Aram F. Hezel, Anup Kasi, Nehal J. Lakhani, Alexander I. Spira, Rajwanth Veluswamy, Chenming Xu, Hisaki Fujii, Stanley Gill, Ho-Jin Lee, William Bennion McKean

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3178

Source: Full article

---

Abstract

TPS3178